Tuesday 11 December, 2007

Lipitor Litigation Pfizer Sues Cobalt

Pfizer Inc. has alleged that when Cobalt Pharmaceuticals Inc. filed a New Drug Application for a product whose active ingredient would be atorvastatin sodium, the Canadian generics outfit infringed a patent covering the blockbuster cholesterol drug Litpitor.Pfizer and a group of subsidiaries including Warner Lambert Co. filed a suit against Cobalt on Friday in federal court in Boston. The suit accused Cobalt of infringing a patent owned by Warner Lambert

No comments:

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker